Medical device coverage rarely gets this much room to breathe. This feed bundles more than a dozen shows from one network into a single subscription, so the mix shifts week to week without ever leaving the industry. The spine is the weekly episode. It opens with a news segment, then moves into a longer sit-down with someone running a company. The guest list runs to chief executives, commercial vice presidents and founders rather than analysts. Surgical robotics comes up constantly and from several angles. One episode makes the case that fast followers still have opportunity in surgical robotics. Another looks at how Distalmotion positions Dexter for ambulatory surgery centers within a broader robotics picture. Webinar previews add more: soft tissue robotics, accessibility-focused systems, robotics and AI applied to eye surgery. Monitoring and connected care get similar treatment, including a Medtronic conversation about using technology and partnerships to widen acute care monitoring. The branded series broaden the map. Abbott Talks spends a season on connected neuromodulation platforms and what they might mean for chronic pain and movement disorder patients, with a co-host structure that gives the conversations an easy back-and-forth. Career stories surface regularly too. A leader explains why she left a large device company to run a small cerebrospinal fluid startup. Another describes realizing that her hand-built prototypes were a supercar when the world needed a Camry, and shifting toward entrepreneurship because of it. That kind of candor sits comfortably beside talk of market strategy and competitive positioning. The hosting is warm and unguarded. Travel gripes, sick weeks and scheduling mishaps make it into the tape. Sponsors, conference registration codes and event agendas are read out plainly before the interviews start, which is part of the deal here: the network runs live events and the podcast is openly connected to them. Listeners who want adversarial reporting on the device industry should look elsewhere. What this offers instead is access, and a lot of it. The value is in hearing operators describe strategy, product direction and commercial reality in their own terms, at length, across orthopedics, neurology, structural heart, monitoring and AI in device development. For anyone working in or selling into medtech, it functions as a standing briefing.